tiprankstipranks
Jacobio Pharmaceuticals Group Co., Ltd. (HK:1167)
:1167
Hong Kong Market
1167
Jacobio Pharmaceuticals Group Co., Ltd.
RESEARCH TOOLSreports

Jacobio Pharmaceuticals Group Co., Ltd. (1167) Stock News & Sentiment

6 Followers
Jacobio Secures US$100 Million Upfront From AstraZeneca for Pan-KRAS Cancer Drug
Premium
Company Announcements
Jacobio Secures US$100 Million Upfront From AstraZeneca for Pan-KRAS Cancer Drug
15d ago
1167
Jacobio Pharma: Differentiated Pan-KRAS Profile, Multiple Clinical Catalysts, and Solid Balance Sheet Underscore Buy Rating
Premium
Ratings
Jacobio Pharma: Differentiated Pan-KRAS Profile, Multiple Clinical Catalysts, and Solid Balance Sheet Underscore Buy Rating
1M ago
Jacobio Wins China KRAS Drug Approval and Strikes US$2 Billion AstraZeneca Deal
Premium
Company Announcements
Jacobio Wins China KRAS Drug Approval and Strikes US$2 Billion AstraZeneca Deal
1M ago
1167
Jacobio Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
Jacobio Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results
2M ago
1167
Jacobio’s First-in-Human JAB-8263 Trial Moves Forward, Keeping Oncology Pipeline in Focus
Premium
Company Announcements
Jacobio’s First-in-Human JAB-8263 Trial Moves Forward, Keeping Oncology Pipeline in Focus
3M ago
1167
Jacobio’s JAB-2485 Trial Progress: Early Cancer Data in Focus for HK:1167 Investors
Premium
Company Announcements
Jacobio’s JAB-2485 Trial Progress: Early Cancer Data in Focus for HK:1167 Investors
3M ago
1167
Jacobio Strikes Up to US$1.9 Billion Global KRAS Inhibitor Deal With AstraZeneca
Premium
Company Announcements
Jacobio Strikes Up to US$1.9 Billion Global KRAS Inhibitor Deal With AstraZeneca
4M ago
1167
More HK:1167 News >

1167 News on the Web

Jacobio Secures US$100 Million Upfront From AstraZeneca for Pan-KRAS Cancer Drug
TipRanks News
Bullish
Huachuang Securities Sticks to Its Buy Rating for Jacobio Pharmaceuticals Group Co., Ltd. (1167)
TipRanks News
Bullish
Jacobio Pharma: Differentiated Pan-KRAS Profile, Multiple Clinical Catalysts, and Solid Balance Sheet Underscore Buy Rating
TipRanks News
Bullish
Jacobio Wins China KRAS Drug Approval and Strikes US$2 Billion AstraZeneca Deal
TipRanks News
Bullish
Jacobio Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results
TipRanks News
Neutral
Jacobio Pharmaceuticals Group Co., Ltd. (1167) Receives a Buy from Huachuang Securities
TipRanks News
Neutral
Jacobio’s First-in-Human JAB-8263 Trial Moves Forward, Keeping Oncology Pipeline in Focus
TipRanks News
Bullish
Jacobio’s JAB-2485 Trial Progress: Early Cancer Data in Focus for HK:1167 Investors
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:1167’s Media Buzz Sentiment?
Currently, no data Available
What is HK:1167’s weekly average amount of articles?
Currently, no data Available
What is HK:1167’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TXTMProText Mobility
STAAStaar Surgical
ALLOAllogene Therapeutics
REPLReplimune Group
IVVDInvivyd
Showing the stocks with the most bullish news sentiment over the past week